[1]李欢欢,敬兴果,庞华,等.99Tcm-MDP骨显像肝脏异常显影原因分析[J].国际放射医学核医学杂志,2017,41(1):15-18.[doi:10.3760/cma.j.issn.1673-4114.2017.01.003]
 Li Huanhuan,Jing Xingguo,Pang Hua,et al.Analysis of abnormal liver uptake of 99Tcm-MDP in bone scan[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(1):15-18.[doi:10.3760/cma.j.issn.1673-4114.2017.01.003]
点击复制

99Tcm-MDP骨显像肝脏异常显影原因分析(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
41
期数:
2017年第1期
页码:
15-18
栏目:
论著
出版日期:
2017-01-25

文章信息/Info

Title:
Analysis of abnormal liver uptake of 99Tcm-MDP in bone scan
作者:
李欢欢 敬兴果 庞华 段东 程刚
400000, 重庆医科大学附属第一医院核医学科
Author(s):
Li Huanhuan Jing Xingguo Pang Hua Duan Dong Cheng gang
Department of Nuclear Medicine, First Affiliated Hospital of Chongqing Medical University, Chongqing 400000, China
关键词:
99m锝美罗酸盐骨显像肝脏异常摄取
Keywords:
Technetium Tc 99m methylenediphosphonateBone imagingLiverAbnormal uptake
DOI:
10.3760/cma.j.issn.1673-4114.2017.01.003
摘要:
目的 分析99Tcm-MDP全身骨显像肝脏异常显影的可能原因。方法 回顾性分析2013年1月至2015年7月于我院核医学科行99Tcm-MDP全身骨显像患者中肝脏异常显影20例,显像结果与其他影像学检查和(或)病理结果、实验室检查进行对比分析。结果 20例肝脏异常显影的患者中,原发性肝损伤3例、继发性肝损伤17例[其中包括多发性骨髓瘤引发肝功能异常1例,恶性肿瘤化疗后肝功能异常8例,肿瘤肝转移7例(结肠癌肝转移5例、肝癌肝内转移1例、肺癌肝转移1例)、慢性肾衰竭铁剂治疗后肝脏摄取1例]。结论 99Tcm-MDP全身骨显像肝脏异常显影的原因较多,除显像技术原因外,应警惕各种原因导致的肝脏损伤,为患者提前进行临床干预提供一定参考。
Abstract:
Objective To analyze the possible causes of liver uptake in 99Tcm-MDP bone scan. Methods A retrospective analysis was performed on 20 cases of abnormal liver uptake in bone scan in our hospital from January 2013 to July 2015. The results were compared with other imaging examinations and/or pathological findings and laboratory examinations. Results Twenty patients were found to have abnormal liver uptake of the imaging agent, including 3 cases with primary liver injury, 17 cases with secondary liver injury, which include 1 case with multiple myeloma and 7 cases with liver metastasis(5 cases with colorectal cancer, 1 with from hepatocellular carcinoma, 1 case with lung cancer), and 1 case of liver uptake after iron treatment. Conclusion Abnormal liver uptake of 99Tcm-MDP in bone imaging is associated with several reasons; barring technical reasons, we should be alert to the liver injury caused by various reasons to provide reference for patients prior to clinical intervention.

参考文献/References:

[1] Zuckier LS, Freeman LM.Nonosseous, nonurologic uptake on bone scintigraphy:Atlas and analysis[J].Semin Nucl Med, 2010, 40(4):242-256.DOI:10.1053/j.semnuclmed.2010.02.003.
[2] 谭天秩.临床核医学[M].2版.北京:人民卫生出版社, 2003:876.Tan TZ.Clinical Nuclear Medicine[M].2nd ed.Beijing:People’s Medical Publishing House, 2003:876.
[3] Romyn AM, Bushnell DL, Freeman ML, et al.Visualization of metastatic liver disease on Technetium-99m bone scintigraphy[J].Clin Nucl Med, 1987, 12(4):264-267.
[4] Parker GE, Burke JT.Technetium-99m-medronate uptake in hepatic necrosis associated with Buddi-Chiari syndrome[J].J Nucl Med, 1992, 33(7):1390-1392.
[5] Jones DN, Lew W, Wycherley AG.Hepatic uptake of a bone scan agent(99mTc-MDP) in apatient with amyloidosis associated with plasma cell dyscrasia[J].Australa Radiol, 1994, 38(1):61-63.
[6] Eshima M, Shiozaki H, Ishino Y, et al.Diffuse liver uptake of Tc-99m phosphate compound associated with intravenous injection of Iron colloid solution[J].Clin Nucl Med, 1993, 18(4):348-349.
[7] Qiu L, Tang Y, Chen Y, et al.The effect of MRI contrast agents on hepatic and splenic uptake in the rabbit during 99mTc-MDP bone scintigraphy[J].Contrast Media Mol Imaging, 2015,10(6):438-445.DOI:10.1002/cmmi.1646.
[8] Zhang W, Chen B, Deng H, et al.Hepatic and splenic uptake on bone scintigraphy in patients with intravenous administration of 99mTc methylene diphosphonate prior to gadolinium-containing contrast[J].Clin Nucl Med, 2013, 38(3):219-220.DOI:10.1097/RLU.0b013e3182814c95.
[9] Shih WJ, Coupal J.Diffuse and intense Tc-99m HMDP localization in the liver due to hypoxia secondary to respiratory failure[J].Clin Nucl Med, 1994, 19(2):116-120.
[10] Hakim S, Joo KG, Baeumler GR.Visualization of acute hepatic necrosis with a bone imaging agent[J].Clin Nucl Med, 1985, 10(10):697-698.
[11] Flynn BM, Treves ST.Diffuse hepatic uptake of technetium-99m methylene diphosphonate in a patient receiving high dose methotrexate[J].J Nucl Med, 1987, 28(4):532-534.
[12] Chen P, Marentis T, Brown RK.Diffuse liver uptake on 99mTc-MDP bone scan secondary to severe hepatic failure[J].Clin Nucl Med, 2014, 39(7):658-659.
[13] 倪秀雄, 姚琦, 林秀珍, 等.环磷酰胺致S180荷瘤小鼠肝损伤机制的实验试验研究[J].福建医药杂志, 2004, 26(2):93-94.Ni XX, Yao Q, Lin XZ, et a1.A study on mechanisms of liver injuries induced by cyclophosphamide in S180 mice[J].FuJian Med J, 2004, 26(2):93-94.
[14] Romyn AM, Bushnell DL, Freeman ML, et al.Visualization of metastatic liver disease on technetium-99m bone scintigraphy[J].Clin Nucl Med, 1987, 12(4):264-267.

相似文献/References:

[1]任佳忠,李永梅,刘岩,等.99Tcm-MDP骨显像胸部异常放射性摄取的原因分析[J].国际放射医学核医学杂志,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
 Jiazhong,Li Yongmei,Liu Yan,et al.Reasons for the abnormal 99Tcm-MDP uptake in the thoracic tissue on bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
[2]李欢欢,李素平,游金辉.小细胞肺癌伴副肿瘤综合征患者骨显像示肌肉摄取一例[J].国际放射医学核医学杂志,2014,38(2):140.[doi:10.3760/cma.j.issn.1673-4114.2014.02.016]
[3]高建青,魏玲格,傅鹏,等.放射性核素骨显像对骨肿瘤样病变的影像学研究价值[J].国际放射医学核医学杂志,2014,38(4):266.[doi:10.3760/cma.j.issn.1673-4114.2014.04.014]
 Gao Jianqing,Wei Lingge,Fu Peng,et al.Value of imaging research in tumor-like disorders by radionuclide bone imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):266.[doi:10.3760/cma.j.issn.1673-4114.2014.04.014]
[4]刘道佳,唐明灯,林端瑜,等.99Tcm-MDP全身骨显像、99Tcm-MDP SPECT-CT和18F-FDG SPECT-CT探测脊柱转移瘤的比较[J].国际放射医学核医学杂志,2011,35(2):89.[doi:10.3760/cma.j.issn.1673-4114.2011.02.006]
 LIU Dao-jia,TANG Ming-deng,LIN Duan-yu,et al.Comparision of the value of 99Tcm-MDP bone scintigraphy, 99Tcm-MDP SPECT-CT and 18F-FDG SPECT-CT in detecting bone metastases of spine[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):89.[doi:10.3760/cma.j.issn.1673-4114.2011.02.006]
[5]王渊恺,袁杰,张光明,等.鼻咽癌在全身骨显像鼻部感兴趣区放射性异常的分析[J].国际放射医学核医学杂志,2011,35(1):20.[doi:10.3760/cma.j.issn.1673-4114.2011.01.006]
 WANG Yuan-kai,YUAN Jie,ZHANG Guang-ming,et al.Study on nasal radioactive anomalies of nasopharyngeal carcinoma in bone imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):20.[doi:10.3760/cma.j.issn.1673-4114.2011.01.006]
[6]徐海青,段俊,吴边.全身骨显像诊断前列腺癌骨转移与PSA水平及病理分级的相关性研究[J].国际放射医学核医学杂志,2011,35(1):34.[doi:10.3760/cma.j.issn.1673-4114.2011.01.010]
 XU Hai-qing,DUAN Jun,WU Bian.Study of relationship between the bone imaging, level of PSA and pathology grade in diagnosis of prostate carcinoma bone metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):34.[doi:10.3760/cma.j.issn.1673-4114.2011.01.010]
[7]苏莉,黄诚刚,牛文强,等.25例血清PTH升高的甲状旁腺相关疾病患者的诊断[J].国际放射医学核医学杂志,2010,34(2):84.[doi:10.3760/cma.j.issn.1673-4114.2010.02.005]
 SU Li,HUANG Cheng-gang,NIU Wen-qiang,et al.Nuclear medicine diagnostic experience for 25 patients with parathyroid disease accompanied elevated serum PTH level[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):84.[doi:10.3760/cma.j.issn.1673-4114.2010.02.005]
[8]黄诚刚,陈小艳,马春清,等.血清FPSA/TPSA及性腺激素测定结合核素骨显像在前列腺癌诊断、复发和转移中的临床价值[J].国际放射医学核医学杂志,2010,34(6):337.[doi:10.3760/cma.j.issn.1673-4114,2010.06.005]
 HUANG Cheng-gang,CHEN Xiao-yan,MA Chun-qing,et al.Evaluation of serum FPSA/TPSA and hormone determination combinded with nuclide bone imaging in diagnosis of prostate carcinoma and its recidivation and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):337.[doi:10.3760/cma.j.issn.1673-4114,2010.06.005]
[9]陶欣慰,黄钢.18F-FDGPET与99Tcm-MDP骨显像在诊断肿瘤骨转移中的比较[J].国际放射医学核医学杂志,2010,34(6):352.[doi:10.3760/cma.j.issn.1673-4114,2010.06.008]
 TAO Xin-wei,HUANG Gang.Comparasion of 18F-FDG PET and 99Tcm-MDP bone imaging in diagnosis of bone metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):352.[doi:10.3760/cma.j.issn.1673-4114,2010.06.008]
[10]冯菲,赵德善,耿会霞,等.原发性腹膜砂粒体癌99Tcm-亚甲基二膦酸盐SPECT-CT全身骨显像一例报告[J].国际放射医学核医学杂志,2009,33(5):285.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.009]
[11]张瑞国,贾强,谭建.99Tcm-MDP全身骨显像腹盆部软组织异常显影的原因分析[J].国际放射医学核医学杂志,2018,(5):458.[doi:10.3760/cma.j.issn.1673-4114.2018.05.013]
 Zhang Ruiguo,Jia Qiang,Tan Jian.Analysis of abdominal and pelvic extraosseous uptake of 99Tcm-methylene diphosphonate on bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(1):458.[doi:10.3760/cma.j.issn.1673-4114.2018.05.013]

备注/Memo

备注/Memo:
收稿日期:2016-07-26。
基金项目:国家临床重点专科建设项目(国卫办医函[2013]544号)
通讯作者:敬兴果,Email:1225298848@qq.com
更新日期/Last Update: 1900-01-01